Sg Americas Securities, LLC Alx Oncology Holdings Inc Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 27,394 shares of ALXO stock, worth $46,295. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,394

Previous 20,506 33.59%

Holding current value

$46,295

Previous $124,000 59.68%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$1.81 - $8.13 $12,467 - $55,999	6,888 Added 33.59%	27,394 $50,000
Q2 2024 Jul 12, 2024	SELL	$5.84 - $17.56 $19,856 - $59,703	-3,400 Reduced 14.22%	20,506 $124,000
Q1 2024 May 06, 2024	SELL	$10.95 - $16.79 $70,539 - $108,161	-6,442 Reduced 21.23%	23,906 $267,000
Q4 2023 Jan 12, 2024	BUY	$4.81 - $15.38 $97,541 - $311,891	20,279 Added 201.4%	30,348 $452,000
Q3 2023 Oct 13, 2023	BUY	$4.19 - $7.35 $42,189 - $74,007	10,069 New	10,069 $48,000
Q3 2022 Oct 31, 2022	BUY	$8.23 - $15.14 $14,937 - $27,479	1,815 Added 3.73%	50,536 $484,000
Q2 2022 Jul 29, 2022	BUY	$5.89 - $19.46 $80,074 - $264,558	13,595 Added 38.7%	48,721 $394,000
Q1 2022 Apr 29, 2022	BUY	$13.65 - $22.06 $9,322 - $15,066	683 Added 1.98%	35,126 $594,000
Q4 2021 Feb 07, 2022	BUY	$21.49 - $74.4 $525,323 - $1.82 Million	24,445 Added 244.5%	34,443 $740,000
Q3 2021 Nov 01, 2021	BUY	$52.51 - $80.91 $425,488 - $655,613	8,103 Added 427.6%	9,998 $738,000
Q2 2021 Aug 12, 2021	SELL	$52.2 - $75.23 $71,044 - $102,388	-1,361 Reduced 41.8%	1,895 $104,000
Q1 2021 May 13, 2021	BUY	$62.84 - $87.68 $204,607 - $285,486	3,256 New	3,256 $240,000

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $68.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Alx Oncology Holdings Inc Transaction History